Pet Docter (萌爪爪)

Bei Jing Shi, China

Veterinary AI / ML Diagnostics Information & Knowledge Services

Pet Docter (萌爪爪): Developed by the AI algorithm team of Kuai Miao Technology and a team of veterinarians, this generative PhmdGPT large language model in the field of pet medicine is pretrained with medical big data from 1.1 million dogs and 1.7 million cats, totaling 6.2 million medical records, along with specialized knowledge in veterinary medicine. Through voice, text, and image-based interactive dialogue, it can accurately identify common diseases, automatically generate treatment plans involving medication and diet, answer pet owners' daily pet care questions, and intelligently recommend pet health care services. Additionally, as an AI large language model, it can assist veterinarians in diagnosing conditions, answering patient inquiries, translating medical terminology, and more. Furthermore, by utilizing a vast amount of pet medical texts and data, the PhmdGPT large model can be applied in the development of veterinary drugs, addressing issues related to medication...

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Pet Docter (萌爪爪) on @MedStartr Today #Veterinary #AIML #Diagnostics #InformationKnowledgeServices #MedMo #MedStartrVentures

https://www.medstartr.ai/s/BgTjTB0B97Q

Get Involved in Pet Docter (萌爪爪)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2020
Website: www.petdocter.com

Technologies

LLMsAI/Machine LearningDiagnostic Decision Support

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Pet Docter (萌爪爪)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.